✦ LIBER ✦

Aspirin or clopidogrel for secondary prevention of cardiovascular events: is there a winner?

✍ Scribed by Jean-Michel Gaspoz; Philippe de Moerloose

Book ID: 116210218
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 51 KB
Volume: 116
Category: Article
ISSN: 1555-7162
DOI: 10.1016/j.amjmed.2004.03.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of Clopidogrel plus A

Cost-Effectiveness of Clopidogrel plus Aspirin versus Aspirin Alone for Secondary Prevention of Cardiovascular Events: Results from the CHARISMA Trial

✍ Jersey Chen; Deepak L. Bhatt; Elizabeth Schneider Dunn; Chunxue Shi; J. Jaime Ca 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Aspirin for Primary Prevention of Cardio

Aspirin for Primary Prevention of Cardiovascular Disease Events

✍ Carrie W. Nemerovski; Francine D. Salinitri; Kathryn A. Morbitzer; Lynette R. Mo 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Cost Effectiveness of Aspirin, Clopidogr

Cost Effectiveness of Aspirin, Clopidogrel, or Both for Secondary Prevention of Coronary Heart Disease

✍ Gaspoz, Jean-Michel; Coxson, Pamela G.; Goldman, Paula A.; Williams, Lawrence W. 📂 Article 📅 2002 🏛 Massachusetts Medical Society 🌐 English ⚖ 109 KB

A comparison of aspirin and clopidogrel

A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding

✍ Fei-Yuan Hsiao; Yi-Wen Tsai; Weng-Foung Huang; Yu-Wen Wen; Pei-Fen Chen; Po-Yin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Economic Evaluation of Clopidogrel Plus

Economic Evaluation of Clopidogrel Plus Aspirin for Secondary Prevention of Cardiovascular Events in Canada for Patients With Established Cardiovascular Disease: Results From the CHARISMA Trial

✍ Jersey Chen; Chunxue Shi; Elizabeth M. Mahoney; Elizabeth Schneider Dunn; Stépha 📂 Article 📅 2011 🏛 Pulsus Group Inc 🌐 English ⚖ 751 KB

Clopidogrel versus aspirin for secondary

Clopidogrel versus aspirin for secondary prophylaxis of vascular events: A cost-effectiveness analysis

✍ M.D. Schleinitz; J.P. Weiss; D.K. Owens 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 39 KB